Skip to main content
TELCON RF PHARMACEUTICAL. Inc. logo

TELCON RF PHARMACEUTICAL. Inc. — Investor Relations & Filings

Ticker · 200230 ISIN · KR7200230001 KO Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2025-07-30 Major Shareholding Noti…
Country KR South Korea
Listing KO 200230

About TELCON RF PHARMACEUTICAL. Inc.

http://www.telcon-rf.com

TELCON RF PHARMACEUTICAL. Inc. operates across two primary business segments: radio frequency (RF) components and pharmaceuticals. The RF division specializes in the development, manufacturing, and global sale of components for wireless communication equipment. Its main products include RF coaxial connectors, cable assemblies, coaxial couplers, and distributors. The pharmaceutical and biotechnology division is engaged in the development and sale of medicinal products.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This document details changes in share ownership by a major shareholder (주식회사 뉴온) in the issuing company (주식회사 텔콘알에프제약). In the context of financial filings, this is classified as a Major Shareholding Notification (MRQ) as it reports changes in significant share ownership levels.
2025-07-30 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It specifically details a contract amendment (정정신고) due to an automatic renewal of the contract period. Since this document is a specific regulatory disclosure regarding a commercial contract and does not fit into categories like financial reports, board changes, or shareholder meetings, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback for miscellaneous corporate announcements.
2025-07-11 Korean
유상증자1차발행가액결정
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Telcon RF Pharmaceutical regarding the determination of the '1st issue price' for a paid-in capital increase (rights offering). It details the calculation methodology, the number of shares, and the timeline for the final issue price. This falls under capital structure changes and financing activities, specifically related to share issuance.
2025-07-03 Korean
[기재정정]주요사항보고서(유무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Telcon RF Pharmaceutical regarding a decision on paid-in and bonus capital increases (유무상증자결정). It details the purpose of funds, issuance price, subscription dates, and allocation methods. This type of filing, which details changes to the company's capital structure through share issuance, falls under the 'Share Issue/Capital Change' category.
2025-07-03 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 98% confidence The document is a '증권신고서(지분증권) [발행조건확정]' (Securities Registration Statement - Equity Securities [Issuance Terms Confirmed]) filed with the Financial Services Commission in South Korea. It details the finalization of the issuance price for a capital increase (rights offering). This type of document is a regulatory filing related to capital structure changes and financing, which falls under the 'Share Issue/Capital Change' (SHA) category in the provided schema.
2025-07-03 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 98% confidence The document is a 'Investment Prospectus' (투자설명서) amendment (정정신고) filed by Telcon RF Pharmaceutical. It details changes to the offering price (1차 발행가액 확정) and updates related financial risk factors and capital usage plans. In the context of financial filings, a prospectus amendment is a regulatory document that provides updated information to potential investors regarding a capital raise. Since it is a formal regulatory filing for a securities offering, it falls under the 'Regulatory Filings' category as the most appropriate classification for this type of document in the provided schema.
2025-07-03 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.